Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 48 Neoplasms 43 Depression 31 Fatigue 30 Prostatic Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 18 Lymphoma, Large B-Cell, Diffuse 17 Multiple Myeloma 16 Carcinoma, Non-Small-Cell Lung 16 Lymphoma, Non-Hodgkin 15 Lung Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Lymphoma, Mantle-Cell 14 Leukemia, Myeloid, Acute 14 Hodgkin Disease 14 Colorectal Neoplasms 14 Burkitt Lymphoma 14 Anxiety Disorders 14 Pain 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Head and Neck Neoplasms 11 Blast Crisis 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Hairy Cell 10

Interventions

Gemcitabine 9 pembrolizumab 7 Cisplatin 5 enfortumab vedotin 4 atezolizumab 4 Trastuzumab 4 Mitomycin 4 Carboplatin 4 Sunitinib 3 Pemetrexed 3 dodecyl maltoside 2 cabozantinib 2 Water 2 Sugammadex 2 Standard of Care 2 Saline Solution 2 Paclitaxel 2 Nivolumab 2 Neostigmine 2 Docetaxel 2 Cetuximab 2 Bevacizumab 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 vinflunine 1 valrubicin 1 tucatinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Therapeutics × Clear all

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡